Since its emergence in 2019, SARS-CoV-2 has continued to evolve, with new variants of concern impacting transmissibility, severity, and immunity. Vulnerable groups—including children, pregnant women, and people living with HIV—have been disproportionately affected. At the same time, the trajectory of mpox outbreaks in non-endemic countries remains uncertain, with evolving epidemiology shaped by vaccination programmes, national responses, and viral evolution.
To address these challenges, the VERDI initiative conducts observational cohort studies to better understand the impact of SARS-CoV-2 variants and mpox with specific populations. In 2022, VERDI received EU funding to launch Work Package 7 (MPX and Preparedness), which focuses on mpox research. and strengthening international research preparedness across Europe and beyond. VERDIQual (led by University College London) specifically focused on conducting qualitative research (including community focus group discussions, and analysis of news and social media) in the UK, Italy, Nigeria and Thailand.
Community engagement is a cornerstone of this approach. To this end, VERDIQual commissioned the European AIDS Treatment Group (EATG) and NAZ (a London-based sexual health charity) to establish and co-lead a VERDIQual Mpox Community Advisory Group, ensuring that lived experiences and community perspectives inform research and preparedness planning.
The VERDI Mpox Community Advisory Group is made up of 8 members, including two joint chairs, who belong to communities that are affected by mpox. These members are anticipated to offer diverse perspectives, backgrounds, and experiences, ensuring comprehensive representation within the group.
Join us on 22 October (13:00–14:00 CET) to learn more about the VERDIQual research findings in Europe and to discuss with community members and researchers practical steps for strengthening outbreak preparedness and response at both local and European levels.
https://us06web.zoom.us/meeting/register/a862q027T0KUuqXUZr48yw
13:00-13:05 CET | Welcome & Introduction | CAB Co-Chairs: Willian Gomes (EATG) & Jaime Sylla (NAZ) |
13:05–13:20 CET | Presentation of VERDIQual findings (Europe) + Q&A | Dr Shema Tariq (UCL) |
13:20-13:30 CET | Q&A | Moderator: TBC |
13:30-13:50 CET | Debate on how we can build a stronger structure of action for the next outbreak, including a local and European plan | CAB Co-Chairs: Willian Gomes (EATG) & Jaime Sylla (NAZ)
|
13:50-14:00 CET | Q&A/Discussion & Closing remarks | CAB Co-Chairs: Willian Gomes (EATG) & Jaime Sylla (NAZ) |
Questions about the event? Email:
The VERDI project (101045989) is funded by the European Union. Views and opinions expressed are however those of the VERDI Consortium only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.